Joe Newell, Chief Operations Officer at Atara Biotherapeutics, Inc. (ATRA), sold 7,772 shares at $20.39 ($158K) on 2021-02-08, disclosed to the SEC on 2021-02-09.
Seasonal sale ($158k) by Chief Operations Officer — this insider has traded ATRA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.39 | 3,886 | $79K | 50.0% |
| 2 | $20.39 | 3,886 | $79K | 50.0% |
| Total | $20.39 avg | 7,772 | $158K | 100% |
| Filing → |
| ATRA | SELL | 2021-09-24 | $179K | — | Filing → |
| ATRA | SELL | 2021-09-17 | $49K | — | Filing → |
| ATRA | SELL | 2021-08-31 | $53K | — | Filing → |